These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27063550)

  • 41. Drug safety evaluation of naltrexone/bupropion for the treatment of obesity.
    Verpeut JL; Bello NT
    Expert Opin Drug Saf; 2014 Jun; 13(6):831-41. PubMed ID: 24766397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacotherapy for the management of obesity.
    Patel D
    Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy of five long-term weight loss drugs: quantitative information for medication guidelines.
    Dong Z; Xu L; Liu H; Lv Y; Zheng Q; Li L
    Obes Rev; 2017 Dec; 18(12):1377-1385. PubMed ID: 29024559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Past, present and future of pharmacotherapy for obesity.
    Benaiges D; Pedro-Botet J; Flores-Le Roux JA; Climent E; Goday A
    Clin Investig Arterioscler; 2017; 29(6):256-264. PubMed ID: 28935287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical treatment of obesity: the past, the present and the future.
    Bray GA
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):665-84. PubMed ID: 25194183
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A concise review on the therapeutics of obesity.
    Bray GA
    Nutrition; 2000 Oct; 16(10):953-60. PubMed ID: 11054601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity treatment: novel peripheral targets.
    Field BC; Chaudhri OB; Bloom SR
    Br J Clin Pharmacol; 2009 Dec; 68(6):830-43. PubMed ID: 20002077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New centrally acting agents for appetite control: from biological mechanisms to clinical efficacy.
    Catoira NP; Viale L; Di Girolamo G; Gonzalez C
    Curr Med Res Opin; 2014 Jun; 30(6):961-9. PubMed ID: 24432840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological approaches for the treatment of obesity.
    Fernández-López JA; Remesar X; Foz M; Alemany M
    Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of obesity: an update on anti-obesity medications.
    Halpern A; Mancini MC
    Obes Rev; 2003 Feb; 4(1):25-42. PubMed ID: 12608525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive Review of Current and Upcoming Anti-Obesity Drugs.
    Son JW; Kim S
    Diabetes Metab J; 2020 Dec; 44(6):802-818. PubMed ID: 33389955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gender-related issues in the pharmacology of new anti-obesity drugs.
    Cataldi M; Muscogiuri G; Savastano S; Barrea L; Guida B; Taglialatela M; Colao A
    Obes Rev; 2019 Mar; 20(3):375-384. PubMed ID: 30589980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New obesity agents: lorcaserin and phentermine/topiramate.
    Fleming JW; McClendon KS; Riche DM
    Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obesity medications: what does the future look like?
    Butsch WS
    Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):360-6. PubMed ID: 26313898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological management of obesity in patients with type 2 diabetes.
    Black RL; Higbea AM; Duval C; Chastain LM
    Expert Rev Endocrinol Metab; 2016 Sep; 11(5):415-423. PubMed ID: 30058912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lorcaserin--not a new weapon in the battle with appetite.
    Halford JC
    Nat Rev Endocrinol; 2010 Dec; 6(12):663-4. PubMed ID: 21102648
    [No Abstract]   [Full Text] [Related]  

  • 58. Medications Available for Weight Reduction in Elective Total Joint Arthroplasty.
    Amanatullah DF; Ohanisian L; Bailony R
    JBJS Rev; 2020 Jun; 8(6):e0123. PubMed ID: 33006462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current pharmacotherapy for obesity.
    Srivastava G; Apovian CM
    Nat Rev Endocrinol; 2018 Jan; 14(1):12-24. PubMed ID: 29027993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Status of pharmacotherapy in current care of obese].
    Sucharda P
    Cas Lek Cesk; 2017; 156(6):319-322. PubMed ID: 29212337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.